Ascendis Pharma A/S Appoints Thomas A. Larson as Chief Commercial Officer
COPENHAGEN, Denmark, April 02, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutic... Read More
Ascendis Pharma A/S Reports Full Year 2017 Financial Results
- Rare Disease Endocrinology Pipeline Advances, with Significant Milestones Anticipated Over the Next Twelve Months - ... Read More